Journal of Peking University(Health Sciences) ›› 2017, Vol. 49 ›› Issue (1): 36-042. doi: 10.3969/j.issn.1671-167X.2017.01.006

• Article • Previous Articles     Next Articles

Effect of concentrated growth factors on the treatment of degree Ⅱ furcation involvements of  mandibular molars

QIAO Jing, DUAN Jin-yu, CHU Yi, SUN Chang-zhou△   

  1. (First Clinical Division, Peking University School and Hospital of Stomatology & National Engineering Laboratory for Digital and Material Technology of Stomatology & Beijing Key Laboratory of Digital Stomatology, Beijing 100034, China)
  • Online:2017-02-18 Published:2017-02-18
  • Contact: SUN Chang-zhou E-mail:changzhousun66@126.com
  • Supported by:

    Supported by the National Natural Science Foundation of China (81600868)

Abstract:

Objective: Concentrated growth factors (CGF), a new generation of platelet concentrate products, appears to have more abundant growth factors because of its special centrifugation process. However, there are few studies supporting this. This study was designed to evaluate the effect of CGFs in the treatment of Ⅱ° furcations of mandibular molars. Methods: In the present study, thirty-one Ⅱ° furcation involvements in twenty mandiblular molars were included and randomly divided into two groups. The furcation involvements in the experimental group were treated with bone graft therapy combined with CGFs, and the furcation involvements in the control group were treated with bone graft therapy alone. The clinical examination and cone beam computed tomography (CBCT) were performed at baseline and 1 year post-surgery for the two groups. The changes of clinical and CBCT data at baseline and 1 year post-surgery were compared between the experimental group and the control group. Results: At baseline, there were no significant differences between the two groups in the probing depth (PD), vertical clinical attachment loss (CAL-V) and horizontal clinical attachment loss (CAL-H): PD (7.36±2.32) mm (the experimental group) vs. (7.53±2.06) mm (the control group); CAL-V (8.69±1.65) mm (the experimental group) vs. (8.81±1.53) mm (the control group); CAL-H (5.24±2.01) mm (the experimental group) vs. (5.35±2.14) mm (the control group). At the end of 1 year post-surgery, the clinical parameters of both groups were significantly improved (P<0.001). For the experimental group, the average vertical attachment gain was (2.78±1.66) mm, and the vertical attachment loss was improved significantly compared with the baseline (P<0.001); the average horizontal attachment gain was (2.10±1.89) mm, and the horizontal attachment loss were improved significantly compared with the baseline (P<0.001). Furthermore, the improvement degree of the experimental group was significantly higher than that of the control group (P<0.001). At baseline, there were no statistical differences in the vertical bone loss (BL-V) or horizontal bone loss (BL-H) between the two groups (P>0.05): BL-V (5.08±2.17) mm (the experimental group) vs. (5.84±2.65) mm (the control group); BL-H (5.85±2.13) mm (the experimental group) vs. (6.01±2.27) mm (the control group). At 1 year post-surgery, both groups showed significant radiographic bone gain at vertical and horizontal directions compared with baseline (P<0.001). For the experimental group, the average vertical radiographic bone gain was (2.20±1.98) mm, the horizontal radiographic bone gain was (2.51±2.18) mm, the vertical and horizontal radiographic bone loss were both significantly reduced compared with the baseline (P<0.001). For the control group, the average vertical radiographic bone gain was (1.89±2.15) mm, the horizontal radiographic bone gain was (1.30±2.47) mm, the vertical and horizontal radiographic bone losses were both significantly reduced compared with the baseline (P<0.001). And the experimental group showed significantly higher bone gain at vertical and horizontal directions compared with the control group (P<0.001). Conclusion: Within the limitation of the present study, CGFs showed positive role in the treatment of Ⅱ° furcation involvements of mandibular molars.

Key words: Concentrated growth factors, Furcation defects, Bone graft, Guided tissue regeneration, periodontal

CLC Number: 

  • R781.3
[1] Fei LI,Jing QIAO,Jin-yu DUAN,Yong ZHANG,Xiu-jing WANG. Effect of concentrated growth factors combined with guided tissue regeneration in treatment of classⅡ furcation involvements of mandibular molars [J]. Journal of Peking University (Health Sciences), 2020, 52(2): 346-352.
[2] Wei-ting LI,Peng LI,Mu-zi PIAO,Fang ZHANG,Jie DI. Study on bone volume harvested from the implant sites with different methods [J]. Journal of Peking University(Health Sciences), 2020, 52(1): 103-106.
[3] Shu-wen SHI,Yang MENG,Jian JIAO,Wen-jing LI,Huan-xin MENG,Qing-xian LUAN,Wan-chun WANG. Tooth loss and multivariable analysis after 5-year non-surgical periodontal treatment on molars with furcation involvement [J]. Journal of Peking University(Health Sciences), 2019, 51(5): 913-918.
[4] ZHU Jie,OUYANG Xiang-ying. Observation of bone morphology in furcation defects of mandibular molars using cone beam computed tomography [J]. Journal of Peking University(Health Sciences), 2017, 49(1): 67-070.
[5] CHEN Fei, PAN Shao-xia, FENG Hai-lan. Distribution and content of transforming growth factor-β1 and vascular endothelial growth factor in each layer of concentrated growth factors [J]. Journal of Peking University(Health Sciences), 2016, 48(5): 860-865.
[6] QIAO Jing, DUAN Jin-Yu, SUN Chang-Zhou, LIU Deng-Gao. Effect of regenerative therapy for the furcation involvements of mandibular molars evaluated by cone-beam computed tomography [J]. Journal of Peking University(Health Sciences), 2014, 46(5): 727-732.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!